Sarah E Panzer1, Nancy A Wilson1, Bret M Verhoven2, Ding Xiang1,2, C Dustin Rubinstein3, Robert R Redfield2, Weixiong Zhong4, Shannon R Reese1. 1. Division of Nephrology, Department of Medicine, University of Wisconsin, Madison, WI. 2. Division of Transplant Surgery, Department of Surgery, University of Wisconsin, Madison, WI. 3. Genome Editing and Animal Models Facility, Biotechnology Center, University of Wisconsin, Madison, WI. 4. Department of Pathology, University of Wisconsin, Madison, WI.
Abstract
BACKGROUND: Increasingly, it is being appreciated that B cells have broad roles beyond the humoral response and are able to contribute to and regulate inflammation. The specific role of B cells in the pathogenesis of early allograft inflammation remains unclear. METHODS: To address this question, we generated B cell-deficient (B) Lewis rats via clustered regularly interspaced short palindromic repeats (CRISPR) technology. In a full mismatch transplant model, kidneys from Brown Norway donors were transplanted into B Lewis recipients or wild type Lewis recipients. T cell-mediated rejection was attenuated with cyclosporine. RESULTS: Renal inflammation was reduced at 1 week after transplant (Banff scores for interstitial inflammation, microvascular inflammation, glomerulitis, and C4d) in allografts from B recipients. The reduction in interstitial inflammation was predominantly due to a decline in graft infiltrating macrophages. Intragraft T-cell numbers remained unchanged. In addition, B-cell deficiency was associated with increased T regulatory cells and reduced splenic T follicular helper cells at baseline; and significantly increased intragraft and splenic IL-10 mRNA levels after transplant. In vitro, B and wild type splenic T cells produced similar levels of IFN-γ in response to T cell-specific activation. CONCLUSIONS: B-cell deficiency in this model produced an anti-inflammatory phenotype with a shift toward regulatory T-cell populations, production of anti-inflammatory cytokines (IL-10), and a reduction in allograft inflammation. These findings define a role for B cells to influence the cell populations and mediators involved in the pathogenesis of early allograft inflammation.
BACKGROUND: Increasingly, it is being appreciated that B cells have broad roles beyond the humoral response and are able to contribute to and regulate inflammation. The specific role of B cells in the pathogenesis of early allograft inflammation remains unclear. METHODS: To address this question, we generated B cell-deficient (B) Lewis rats via clustered regularly interspaced short palindromic repeats (CRISPR) technology. In a full mismatch transplant model, kidneys from Brown Norway donors were transplanted into B Lewis recipients or wild type Lewis recipients. T cell-mediated rejection was attenuated with cyclosporine. RESULTS:Renal inflammation was reduced at 1 week after transplant (Banff scores for interstitial inflammation, microvascular inflammation, glomerulitis, and C4d) in allografts from B recipients. The reduction in interstitial inflammation was predominantly due to a decline in graft infiltrating macrophages. Intragraft T-cell numbers remained unchanged. In addition, B-cell deficiency was associated with increased T regulatory cells and reduced splenic T follicular helper cells at baseline; and significantly increased intragraft and splenic IL-10 mRNA levels after transplant. In vitro, B and wild type splenic T cells produced similar levels of IFN-γ in response to T cell-specific activation. CONCLUSIONS:B-cell deficiency in this model produced an anti-inflammatory phenotype with a shift toward regulatory T-cell populations, production of anti-inflammatory cytokines (IL-10), and a reduction in allograft inflammation. These findings define a role for B cells to influence the cell populations and mediators involved in the pathogenesis of early allograft inflammation.
Authors: B A Wasowska; Z Qian; D L Cangello; E Behrens; K Van Tran; J Layton; F Sanfilippo; W M Baldwin Journal: Transplantation Date: 2001-03-27 Impact factor: 4.939
Authors: G N de Graav; M Dieterich; D A Hesselink; K Boer; M C Clahsen-van Groningen; R Kraaijeveld; N H R Litjens; R Bouamar; J Vanderlocht; M Tilanus; I Houba; A Boonstra; D L Roelen; F H J Claas; M G H Betjes; W Weimar; C C Baan Journal: Clin Exp Immunol Date: 2015-05 Impact factor: 4.330
Authors: Sherry D Fleming; Terez Shea-Donohue; Joel M Guthridge; Liudmila Kulik; Thomas J Waldschmidt; Matthew G Gipson; George C Tsokos; V Michael Holers Journal: J Immunol Date: 2002-08-15 Impact factor: 5.422
Authors: M C Copin; C Noel; M Hazzan; A Janin; F R Pruvot; J P Dessaint; G Lelievre; B Gosselin Journal: Transpl Immunol Date: 1995-09 Impact factor: 1.708
Authors: F Porcheray; J W Fraser; B Gao; A McColl; J DeVito; I Dargon; Y Helou; W Wong; T C Girouard; S L Saidman; R B Colvin; A Palmisano; U Maggiore; A Vaglio; R N Smith; E Zorn Journal: Am J Transplant Date: 2013-08-06 Impact factor: 8.086
Authors: M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel Journal: Am J Transplant Date: 2014-02 Impact factor: 8.086
Authors: Nancy A Wilson; Natalie M Bath; Bret M Verhoven; Xiang Ding; Brittney A Boldt; Adarsh Sukhwal; Weixiong Zhong; Sarah E Panzer; Robert R Redfield Journal: Transplantation Date: 2019-07 Impact factor: 5.385
Authors: Shannon R Reese; Nancy A Wilson; Yabing Huang; Lucille Ptak; Kenna R Degner; Ding Xiang; Robert R Redfield; Weixiong Zhong; Sarah E Panzer Journal: Transplantation Date: 2021-07-01 Impact factor: 5.385
Authors: Natalie M Bath; Bret M Verhoven; Nancy A Wilson; Weifeng Zeng; Weixiong Zhong; Lauren Coons; Arjang Djamali; Robert R Redfield Journal: PLoS One Date: 2022-10-13 Impact factor: 3.752